Ubiquitin is a protein of 76 amino acids found in every eukaryotic cell. Although ubiquitin is implicated in ATP-dependent nonlysosomal protein degradation and is also conjugated to specific cellular proteins, the role played by ubiquitin in cellular events has not been defined. We report that purified ubiquitin has intrinsic proteolytic activity and demonstrate that this activity is comparable to that of other well-characterized proteases. Monoclonal antibodies specific to ubiquitin inhibit proteolysis. Ubiquitin has protease activity over a broad pH range with an optimum at pH 8.0. It is stimulated by Ca2+ and is inhibited by high concentrations of phenylmethylsulfonyl fluoride and diisopropyl fluorophosphate. Ubiquitin will cleave proteins at a limited number of sites. We propose that the ubiquitination of a protein can convert that protein into an ad hoc specific protease and models are presented as to how this can play a role in regulating a variety of cellular events.
ubiquitin in cellular events has not been defined. We report that purified ubiquitin has intrinsic proteolytic activity and demonstrate that this activity is comparable to that of other well-characterized proteases. Monoclonal antibodies specific to ubiquitin inhibit proteolysis. Ubiquitin has protease activity over a broad pH range with an optimum at pH 8.0. It is stimulated by Ca2+ and is inhibited by high concentrations of phenylmethylsulfonyl fluoride and diisopropyl fluorophosphate. Ubiquitin will cleave proteins at a limited number of sites. We propose that the ubiquitination of a protein can convert that protein into an ad hoc specific protease and models are presented as to how this can play a role in regulating a variety of cellular events.
Two types of evidence suggest that ubiquitin, a 76-residue protein, plays a fundamental role in diverse biologic processes. First, its primary structure is absolutely invariant in higher eukaryotes from insects to humans (see refs. 1 and 2 for reviews). The presence of ubiquitin in every cell type examined (3) and the absolute conservation of its structure indicate that ubiquitin is involved in functions essential to all eukaryotic life forms. Second, ubiquitin is associated with key molecules and processes that are essential to cellular functions.
Ubiquitin is unusual because it is found as a free molecule and covalently linked to other proteins through peptide or isopeptide bonds involving its COOH-terminal glycine residue and the primary or E-NH2 groups of the ubiquitinated proteins (1) . It has become widely accepted that ubiquitin is a component in the ATP-dependent nonlysosomal protein degradation pathway and that the targeted proteins must be ubiquitinated before they are recognized as substrates for proteolysis (1) . However, the existence of specific ubiquitinprotein conjugates that are not rapidly degraded suggests that ubiquitin may be playing other roles.
The ubiquitinated histones H2A (4) and H2B (5) form one class of specific conjugates. Histones H1, H3, and H4 are not ubiquitinated, suggesting that selective modification of a subset of histones is functionally significant. The ubiquitinated histones are preferentially localized within actively transcribed regions of chromatin and their levels change as cells progress through the cell cycle or respond to stress (1, 2) .
Intrinsic plasma membrane proteins have also been found to be specifically modified by ubiquitination. One of these is a lymphocyte glycoprotein that is involved in specific cellcell recognition (6, 7); another is the receptor for the platelet-derived growth factor, which initiates a series of growth-associated responses as a consequence of binding the growth factor (8) . Ubiquitination of membrane proteins is selective since other types of receptors appear not to be ubiquitinated. Therefore, the specific and stoichiometric ubiquitination of some types of membrane proteins suggests that this posttranslational modification may play a role in receptor function.
Although explicit molecular models for how ubiquitin is involved in diverse cellular events have not been proposed, ubiquitination has generally been viewed as providing signals that are recognized by other enzymes (e.g., proteases) or as altering the structure of conjugates affecting their interaction(s) with other cellular components. In the course of purifying ubiquitin and preparing and characterizing polyclonal and monoclonal antibodies to it, we discovered that ubiquitin has intrinsic proteolytic activity. We present evidence for this activity and propose models that provide a common principle for the roles played by ubiquitin in cells.
MATERIALS AND METHODS
Ubiquitin was purified from outdated human erythrocytes. Briefly, the cells were washed to remove plasma and leukocytes and then were hypotonically lysed in phosphate buffer containing ethanol and chloroform. Addition of the organic solvents precipitated membranes, hemoglobin, and a major fraction of other cytosolic proteins. The soluble fraction was concentrated and fractionated by gel filtration; this was followed by chromatography on hydroxylapatite to yield homogeneous ubiquitin. Homogeneity was confirmed by analysis of the purified material by NaDodSO4/PAGE (9) and silver staining (10) . Isoelectric focusing was performed in 7% polyacrylamide gels on a flat-bed slab unit (Hoefer) according to established procedures (Bio-Rad). Focusing gels were calibrated over the pH range of 3-10 using standard markers (Pharmacia). The purified protein was shown to be ubiquitin by complete amino acid sequence analysis on a gas-phase sequencer (model 470A, ABI). Mouse monoclonal antibodies (mAbs) to ubiquitin were prepared by standard fusion protocols and the epitopes recognized by these mAbs were identified by solid-phase radioimmunoassay using peptides generated from enzymatic cleavage of ubiquitin or prepared by chemical synthesis. Detailed descriptions of the ubiquitin purification and characterization and of the generation and characterization of the mAbs will be reported elsewhere (H.T.S., D. Metzger, M. Morrison, and V.A.F., unpublished). /3-Galactosidase was purified to homogeneity from Escherichia coli strain H3000 (11) and was prepared as a substrate
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for protease activity by heating in 2% NaDodSO4 at 100'C for 2 min. Apomyoglobin was prepared from sperm whale myoglobin (Sigma) by acid/butanol extraction (12) .
Protein concentrations were determined by the method of Lowry et al. (13) using bovine serum albumin as standard.
The assays of protease activities were performed in polypropylene Microfuge tubes at 37TC. In a standard assay, ubiquitin was diluted in assay buffer, 50 mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid (Hepps, pH 8.0) containing 0.1 mM CaCl2; NaDodSO4-denatured p-galactosidase as substrate was added (0.05% NaDodSO4, final) to initiate the reaction. Aliquots were removed at various times and mixed with an equal volume of sample buffer (100 mM TrisHCl, pH 7.5/10 mM EDTA/4% LiDodSO4/40 mM dithiothreitol/10% glycerol/0.1% bromphenol blue) and the mixture was heated at 100'C for 2 min. Aliquots were analyzed by NaDodSO4/PAGE on 10% minigels. Gels were stained with Coomassie blue and the intact ,3-galactosidase band (116 kDa) was quantitated by densitometry.
Hepps was from Calbiochem. N-Ethylmaleimide (MaINEt), phenylmethylsulfonyl fluoride (PhMeSO2F), diisopropylfluorophosphate, N-a-tosyllysine chloromethyl ketone (TLCK), and L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK) were from Sigma. Endoproteinases Lys-C, Arg-C, and Glu-C were from Boehringer Mannheim.
RESULTS
Characterization of Purified Ubiquitin Preparations. Ubiquitin was purified from outdated human erythrocytes as described and shown to be intact ubiquitin (residues 1-76) by primary sequence analysis (data not shown). A typical preparation appeared to contain no proteins other than ubiquitin since analysis of this material by NaDodSO4/PAGE followed by staining with Coomassie brilliant blue and silver disclosed only a single protein band (Fig. LA) . The homogeneity of this material was also demonstrated by its mobility as a single species (pI of 6.75) in isoelectric focusing (Fig. 1B) and by its appearance as a single peak when analyzed by reverse-phase HPLC (RP-HPLC) with detection at 206 nm (data not shown). The silver-staining procedure will detect 5 ng of a typical protein on NaDodSO4/PAGE gels, and thus the purified material (20 ug activities of several other well-characterized specific proteases (Lys-C, Arg-C, and Glu-C proteases) ( Table 1) . The apparent first-order rate constants were proportional to the amounts ofenzyme added. Specific activities were calculated as the rate constant per mM concentration of enzyme subunit. Since it is known that Arg-C, Lys-C, and Glu-C proteases are active as monomers, if ubiquitin is active as a monomer, it would have a specific activity similar to those of Arg-C and Lys-C. On the other hand, if ubiquitin functions as a multimer (e.g., as a tetramer), then its activity would be less than that ofthe more active Glu-C protease by a factor of only 6 .
These specific activity measurements strongly suggest that the proteolytic activity observed in our purified ubiquitin preparations is due to ubiquitin itself. If the activity were due to a contaminating protease with the specific activity of a very active enzyme such as Glu-C protease and had a molecular mass of -25 kDa, then the putative contaminating enzyme would represent -12% of the mass in the ubiquitin sample. This would be >400-fold greater than any single contaminating polypeptide detectable by silver staining in the ubiquitin preparations (Fig. 1) .
The Proteolytic Activity The Proteolytic Activity Is Inhibited by mAbs Against Ubiquitin. To further demonstrate that ubiquitin is responsible for the observed proteolytic activity, we examined a collection of mAbs to human ubiquitin for their ability to inhibit that activity. The structural epitopes of ubiquitin recognized by these antibodies have been determined and will be reported elsewhere (H.T.S., K.W., and V.A.F., unpublished). mAbs were purified by affinity chromatography and were free of contaminating serum proteins as measured by NaDodSO4/PAGE (not shown). Two ubiquitinspecific mAbs, 4-3H8 and 5-2F3, both recognizing an epitope in a region of ubiquitin defined by residues 34-48, inhibited the proteolytic activity, whereas an isotype-matched mAb to an unrelated protein did not (Fig. 3) . The proteolytic activity of 1.5 nmol of ubiquitin was inhibited almost 50% by addition of 1 nmol of mAb 4-3H8 and to a lesser extent by mAb 5-2F3. 0.014 168 Ubiquitin (Ub) and endoproteinases Lys-C, Arg-C, and Glu-C were incubated at the indicated concentrations in the standard assay. *Apparent first-order rate constants were determined for the disappearance of intact /3-galactosidase as described in the text and in the legend to Fig. 2. tSpecific activity (SA) was calculated on a molar basis from the following molecular masses: Ub, 8.5 kDa; Lys-C, 33 kDa; Arg-C, 25 kDa; Glu-C, 27 kDa. Complete titrations could not be performed because of competition between immunoglobulin and substrate at higher concentrations of added antibody (data not shown). Inhibition of the proteolytic activity by mAbs specific to ubiquitin provides further evidence that the activity is a property of ubiquitin and is not due to a contaminating protease.
Characterization of the Protease Activity. Purified ubiquitin had protease activity over a broad pH range with optimal activity at pH 8.0 (data not shown). EDTA and EGTA partially inhibited the activity, and addition of excess CaCl2 (5 mM) completely restored activity (Table 2 ). MgCl2 (5 mM) also restored activity but to only 75% of that with CaCl2 (data not shown). Thus, ubiquitin is stimulated by, but not dependent on, exogenous divalent cations for activity, suggesting that these ions are serving a structural role rather than participating directly in catalysis.
Several standard protease inhibitors were examined for their ability to inhibit ubiquitin activity (Table 2) . MalNEt, TLCK, and TPCK had no effect on activity; however, PhMeSO2F at a concentration of 4 mM inhibited activity by 95%. Diisopropyl fluorophosphate (0.5 mM) also inhibited ubiquitin proteolytic activity. However, diisopropyl fluorophosphate does not covalently associate with the enzyme and this concentration is much greater than that required to inhibit typical serine proteases (E.H. and V.A.F., unpublished). Thus, ubiquitin does not appear to be a typical serine protease and may function by a novel catalytic mechanism.
Ubiquitin Proteolytic Activity Is Heat Labile. Ubiquitin was 100 *5 ct 50 10 15 mAb, Al   FIG. 3 . Proteolytic activity is inhibited by anti-ubiquitin mAbs. Aliquots of mAb stocks (4-3H8, 500 mg/ml; 5-2F3, 600 mg/ml; control, 800 mg/ml) were preincubated for 1 hr at 4°C with ubiquitin (0.65 Mg) in a final volume of 40 Ml. The assay was initiated by shifting to 37°C and the addition of 10 ,l ofB-galactosidase. Protease activity was measured as k1 (see Table 1 ) expressed as the % of activity in the absence of antibody. tTLCK, TPCK, and PhMeSO2F were prepared in absolute ethanol at stock concentrations of 100 mM, 100 mM, and 500 mM, respectively.
WMalNEt was prepared in assay buffer as a 100 mM stock. §EGTA and EDTA were preincubated for 30 min at room temperature with ubiquitin in 50 mM Hepps (pH 8.0) before shift to 370C and addition of substrate.
$After a 30-min incubation with either EGTA or EDTA (as above),
CaCl2 was added to a concentration of 5 mM and the preincubation was continued an additional 30 min before addition of substrate.
inactivated as a protease by heating at 70'C for 30 min or by boiling for 2 min. These conditions mimic those used in established procedures for ubiquitin purification (14, 15) and may explain why other investigators have not detected protease activity in purified ubiquitin preparations. Ubiquitin Selectively Cleaves Other Proteins Including Itself. Although our standard assay for the proteolytic activity of ubiquitin measured the cleavage of f3-galactosidase, ubiquitin also acts on other substrates. Aliquots of sperm whale myoglobin incubated with ubiquitin were analyzed by RP-HPLC (Fig. 4A) . The peak of intact myoglobin disappeared over time and a discrete set of fragments appeared. The number of cleavage sites recognized by ubiquitin appeared to be relatively small because only a few peptides were produced. Autodigestion was demonstrated by incubating pure ubiquitin in 0.05% NaDodSO4. RP-HPLC analysis of the incubation mixtures disclosed extensive degradation (Fig.  4B) . Peptide products from both types of digest were isolated and sequenced to help define cleavage site specificity. Preliminary results demonstrated preference for cleavage on the COOH-terminal side of leucine residues, although cleavages at other residues including glycine, threonine, and glutamine were also observed after long-term incubation. However, the limited number of myoglobin fragments produced during incubation suggests that ubiquitin may require structural features in addition to specific amino acids to define the cleavage sites. Although the proteins used in the in vitro studies were more efficient substrates after being denatured, it does not follow that denaturation is required to expose cleavage sites in other proteins in vivo. DISCUSSION We have presented evidence demonstrating that purified ubiquitin has an intrinsic endoprotease activity and that its specific activity is comparable to other endoproteases. We have been unable to separate the enzymatic activity from ubiquitin. Though other fractionation procedures (e.g., RP- Five hundred micrograms of sperm whale apomyoglobin in 0.5 ml of assay buffer containing 0.1% NaDodSO4 was heated at 70°C for 30 min, diluted to 1 ml with assay buffer, and incubated with 10 ,ug of purified ubiquitin at 37°C. Aliquots were removed at various times, acidified with 0.1% trifluoroacetic acid, and dried. The sample was dissolved in 6 M guanidine hydrochloride/0.1% trifluoroacetic acid and analyzed by HPLC on a reversedphase C18 column developed with a gradient of acetonitrile in 0.1% trifluoroacetic acid. (B) Five hundred micrograms of ubiquitin in 1 ml of assay buffer containing 0.05% NaDodSO4 was incubated at 37°C. Aliquots were taken and analyzed as described above. Noted peaks in the elution profile are solvent peak (S), intact ubiquitin (Ub), and intact apomyoglobin (Mb).
HPLC) can lead to loss of activity, in no case was activity found in a fraction that did not also contain ubiquitin. Further, we have demonstrated that mAbs, specific to epitopes defined by residues 34-48 of ubiquitin, will inhibit this activity. The amino acid sequence of ubiquitin, including residues 34-48, is unique and thus it is likely that ubiquitin is the sole target of these antibodies. Because we could not separate the proteolytic activity from ubiquitin and because mAbs specific for ubiquitin inhibited the activity, we conclude that ubiquitin is a protease.
Differences in purification methods might explain why protease activity has not been detected previously in purified ubiquitin preparations. We demonstrated that the proteolytic activity is destroyed by heating. Thus, it seems likely that other investigators have destroyed this activity of ubiquitin during the heating step that is included in published purification methods (14, 15 functional protease when conjugated to other proteins and thus be regulated, in part, by this specific localization.
As a protease conjugated to other proteins, ubiquitin could function in two modes (Fig. 5) . In one mode, the conjugated ubiquitin could act in cis, processing the conjugate. This could lead either to the degradation of the ligated protein or to the generation of a new functional component. Such a cis activity may be involved in processing ubiquitin itself from its putative polyprotein precursor (16) . In the other mode, the conjugate could act in trans and proteolytically process a separate component that interacts with the conjugate (Fig. 5) . In this context, the ligation of ubiquitin to a protein can be viewed as a novel synthetic and regulatory event since a new specific proteolytic enzyme would be created by coupling a substrate recognition domain to ubiquitin, the catalytic domain.
The conjugation of ubiquitin as a protease with other proteins may provide an explanation for its role in certain biologic events. For example, it may be the proteolytic activity of ubiquitin-histone conjugates that is involved in transcriptional control. By the binding of ubiquitinated H2A in nucleosomes, this proteolytic activity is localized to a site where it may inactivate adjacent regulatory elements (e.g., repressors). Proteolytic inactivation of repressors is a control mechanism for gene expression in bacteria and the destruction of specific regulatory proteins determines the developmental fate of the bacteriophage X (17, 18) . It would be surprising if proteolytic inactivation of repressor-like molecules were not used to control gene expression in eukaryotes as well. In this model for the role of ubiquitin-histone conjugates in regulating transcription, conjugation serves only to localize the protease. Targeting of the conjugate to specific regions of the chromatin must be controlled by other factors. It is possible, however, that the ubiquitination of proteins that bind to specific DNA sequences could play a similar but direct regulatory role.
The discovery that ubiquitin is associated, apparently mole per mole, with the receptor for platelet-derived growth factor suggests that it may be involved in receptor functions (8) . One possibility is that the ubiquitinated receptor, after stimulation by growth factor, may act as a protease in cis and process itself. This autoprocessing may lead to the down-regulation of the receptor (19, 20) or, alternatively, produce a fragment that serves as a second messenger necessary for signal transduction. Another possibility is that the ubiquitinated receptor may act as a protease in trans and process a cellular component that binds specifically to the receptor in response to the binding of the growth factor. This process may parallel the activation of the receptor's intrinsic tyrosine kinase activity (8) . Several mechanisms can be imagined whereby growth factor binding both activates the receptor as a protease and creates a specific substrate binding site for the cellular factor that is to be cleaved.
The models we present are based on the discovery that ubiquitin has protease activity and that ubiquitin is found conjugated to specific proteins involved in regulating cellular events. The general principle of these models is that ubiquitination of a specific protein can convert that protein into an ad hoc proteolytic enzyme, one that is active in a unique set of conditions. For ubiquitin to function as a protease, however, its activity must be tightly regulated. Such regulation would include cellular factors that affect the proteolytic activity itself as well as those enzymes that are involved in ligating ubiquitin to specific proteins. The conditions that govern ubiquitin's proteolytic activity will define its biologic roles.
